CIK 0001862150 · <br>Emerging growth company
Cingulate Inc.
Sign in to watch- Ticker
- CING
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863825535
- Phone
- (913) 942-2300
- Business address
- 1901 W. 47TH PLACE, KANSAS CITY, KS, 66205
- Former names
- Cingulate Inc.
Securities
- CING Common Stock Nasdaq
- CINGW Warrants Nasdaq
- SC 13D/A Stake Beneficial Ownership Report
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,823,155 shares at $0.55 ($1,000,001)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Unregistered share sale
- 8-K Event Delisting notice · Other events
- UPLOAD Other SEC-generated Letter
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
Page 15 of 25 · 494 filings